The efficacy and safety of recombinant human activated protein C for the treatment of patients with severe sepsis (vol 28, pg 48, 2000)

Bernard, GR;LaRosa, SP;Laterre, Pierre-François;Ely, EW;Vincent, JL;et.al.
(2001) Critical Care Medicine — Vol. 29, n° 2, p. 469 (2001)

Files

No attached file found for this publication.

Details

Authors
  • Bernard, GR
    Author
  • LaRosa, SP
    Author
  • Laterre, Pierre-FrançoisUCLouvain
    Author
  • Ely, EW
    Author
  • Vincent, JL
    Author
Show more
Affiliations

Citations

Bernard, G., LaRosa, S., Laterre, P.-F., Ely, E., Dhainaut, J., Fisher, C., Lopez-Rodriguez, A., Helterbrand, J., Steingrub, J., Garber, G., & Vincent, J. (2001). The efficacy and safety of recombinant human activated protein C for the treatment of patients with severe sepsis (vol 28, pg 48, 2000). Critical Care Medicine, 29(2), 469. https://doi.org/10.1097/00003246-200111000-00003 (Original work published 2001)